← Leaderboards
Christopher Michael Sturgeon
Washington University
$5,222,741
Attributed
$7,194,498
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,194,498 · 5
By mechanism
R01$6,761,634 · 4
R21$432,864 · 1
Top collaborators
- James Palis4 shared
- Deepta Bhattacharya2 shared
- Kory J. Lavine2 shared
Most similar at Washington University
Same institution · by research overlap
- Philip A Mudd$1,813,149
- Kenneth M. Murphy$11,514,927
- Kyunghee Choi$18,130,511
- Kristen L Kroll$11,063,709
- Takeshi Egawa$8,683,159
Others in their field
Other Emerging Leaders on “Hematopoietic Stem Cells”
- Bronwen Shaw · Medical College Of Wisconsin$24,584,971
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Daniel Lucas · Cincinnati Childrens Hosp Med Ctr$9,614,171
- Frederic Geissmann · Sloan-Kettering Inst Can Research$7,938,136
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$7,934,488
- Robert A.j. Signer · University Of California, San Diego$7,073,723
Research focus
Hematopoietic Stem CellsHematopoieticCellsIn VitroHuman Pluripotent Stem CellInsightGenetic TranscriptionEmbryoRegenerative MedicineGenerationsProgenitorHematopoiesisBiologyRegulationComplexEmbryonic DevelopmentAdultGrowthProgramsMesodermBioinformaticsCd34 GenePatternProperty
Grant awards (15)
Engineering pluripotent stem cells to evade and promote immunity$599,236
R01 · FY2025 · EB · contact PI
Characterization of multilineage definitive hematopoietic progenitors from human pluripotent stem cells$598,877
R01 · FY2025 · HL · contact PI
Engineering pluripotent stem cells to evade and promote immunity$618,792
R01 · FY2024 · EB · contact PI
Characterization of multilineage definitive hematopoietic progenitors from human pluripotent stem cells$598,877
R01 · FY2024 · HL · contact PI
Embryonic natural killer cell development and function$579,358
R01 · FY2023 · HL · contact PI
Mesodermal Commitment of the Definitive Hematopoietic Program$422,500
R01 · FY2023 · HL · contact PI
Embryonic natural killer cell development and function$588,284
R01 · FY2022 · HL · contact PI
Mesodermal Commitment of the Definitive Hematopoietic Program$422,500
R01 · FY2022 · HL · contact PI
Embryonic natural killer cell development and function$535,182
R01 · FY2021 · HL · contact PI
Mesodermal Commitment of the Definitive Hematopoietic Program$423,334
R01 · FY2021 · HL · contact PI
Role of ontogeny and niche on human macrophage development$236,250
R21 · FY2021 · AI
Embryonic natural killer cell development and function$589,798
R01 · FY2020 · HL · contact PI
Mesodermal Commitment of the Definitive Hematopoietic Program$392,709
R01 · FY2020 · HL · contact PI
Role of ontogeny and niche on human macrophage development$196,614
R21 · FY2020 · AI
Mesodermal Commitment of the Definitive Hematopoietic Program$392,187
R01 · FY2019 · HL · contact PI